The goal of this program is to improve patient counseling about updates to health policy that increase the affordability of health care and prescribing of incretin-based therapy in patients with type 2 diabetes. After hearing and assimilating this program, the clinician will be better able to: 1. Explain the effects of the Inflation Reduction Act (IRA) on patient costs. 2. Assess the implications of reinstatement of state licensure rules following the end of the COVID-19 pandemic. 3. Consider adding medical treatment of opioid use disorder to one s scope of practice. 4. Compare the advantages of different incretin-based therapies. 5. Appropriately select patients for incretin-based therapies.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Family-Medicine
- Start Date: 2024-01-25 06:00:00
- End Date: 2024-01-25 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest